Hongwei Liu

No ORCID on file · 6 papers in corpus
observational 2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1644373

BACKGROUND: Oxidative stress and metabolic disorders significantly contribute to the development of polycystic ovarian syndrome (PCOS). Heme oxygenase-1 (HMOX1) plays a key role in the degradation of heme and the regulation of oxidative str…

observational 2024
Endocrine connections ·doi:10.1530/ec-23-0463

Oxidative stress and metabolic disorders are involved in the pathogenesis of polycystic ovary syndrome (PCOS). Heme oxygenase 2 (HMOX2) plays a critical role in preserving heme metabolism as well as in modulating glycolipid metabolism, oxid…

lab-animal 2021
Cell reports ·doi:10.1016/j.celrep.2021.109942

Anti-viral monoclonal antibody (mAb) treatments may provide immediate but short-term immunity from coronavirus disease 2019 (COVID-19) in high-risk populations, such as people with diabetes and the elderly; however, data on their efficacy i…

observational 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00771

Background: Oxidative stress plays an important role in the pathogenesis of polycystic ovary syndrome (PCOS). Glutathione peroxidase 1 (GPx1) and catalase (CAT) are the major intracellular antioxidant enzymes that can detoxify hydrogen pero…

observational 2018
Lipids in health and disease ·doi:10.1186/s12944-018-0725-5

BACKGROUND: Elevated serum levels of apolipoprotein (apo) C1 may be an early protein marker of metabolic abnormality in women with polycystic ovary syndrome (PCOS). It is not clear, however, whether there are any relationships between the a…

observational 2017
Lipids in health and disease ·doi:10.1186/s12944-017-0448-z

BACKGROUND: The G994T polymorphism in platelet-activating factor acetylhydrolase (PAF-AH) gene is associated with the risk of polycystic ovary syndrome (PCOS). The aim of this study was to investigate the relationship between R92H and A379V…